ArticleAnnals of translational medicine2021
Complete response to pyrotinib combined with letrozole as first-line treatment of HER2-positive/HR-positive breast cancer: a case report.
Ning Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.